North America Transplantation Market Size & Outlook
North America transplantation market, 2018-2030 (US$M)
Related Markets
North America transplantation market highlights
- The North America transplantation market generated a revenue of USD 6,738.8 million in 2023.
- The market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
- In terms of segment, tissue products was the largest revenue generating product in 2023.
- Immunosuppressive Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 6,738.8 million |
| Market revenue in 2030 | USD 11,834.4 million |
| Growth rate | 8.4% (CAGR from 2023 to 2030) |
| Largest segment | Tissue products |
| Fastest growing segment | Immunosuppressive Drugs |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
| Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
Other key industry trends
- In terms of revenue, North America region accounted for 40.7% of the global transplantation market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,930.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transplantation Market Scope
Transplantation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America transplantation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 58.07% in 2023. Horizon Databook has segmented the North America transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the largest share of the global transplantation market owing to increase in the number of organ transplantation procedures and rise in need for organ transplant due to high incidence of organ failures. According to Organ Procurement and Transplantation Network, 118,020 individuals required organ transplantation in the U.S in 2017.
With rise in the number of chronic diseases, such as cancer, kidney diseases, and cardiac disorders, incidence of organ failure has also increased. This has led to high demand for organ donors, which has encouraged opening of a large number of transplant centers in the region, further driving the market.
According to Transplant Observatory, a total of 2,490 organ transplant procedures were performed in Canada, which included 1,437 kidney transplants and 526 liver transplants. With an increase in the number of chronic kidney diseases in the region, there is an additional demand for organ donors in the region.
Reasons to subscribe to North America transplantation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America transplantation market databook
-
Our clientele includes a mix of transplantation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America transplantation market , including forecasts for subscribers. This continent databook contains high-level insights into North America transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America transplantation market size, by country, 2018-2030 (US$M)
North America Transplantation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
